Chatbot providing information for soft tissue sarcoma patients
Part of Cancer clinical trials.
This study tests a chatbot that provides helpful information to people with soft tissue sarcoma who are currently in treatment. It’s designed to support you with answers and resources.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with soft tissue sarcoma.
- You are currently receiving active treatment (any stage).
- You are 18 years or older.
- You can speak Cantonese, Mandarin, or English.
- You have a phone, tablet, or computer that can use a chat app.
- You have not used a chatbot for sarcoma information in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a way to use patient information to help doctors decide which treatment approach may fit best for people with certain bone or soft-tissue tumors. It may help improve selection and care planning, but it depends on whether your data can be used.
This study is for people who have been diagnosed with bone or soft tissue sarcoma confirmed by a tissue test. It may help researchers understand sarcoma better, but you must be able to understand and consent to take part.
This study uses a phone app to track how well people recover after surgery for bone or soft tissue sarcoma. It may help doctors understand how to improve movement and quality of life after treatment.
This study tests whether adding palliative care early on to standard cancer treatment improves quality of life for people newly diagnosed with advanced or metastatic soft tissue sarcoma.
This trial tests a chatbot that gives support and advice to young adults who have finished cancer treatment. It aims to help you manage symptoms and side effects through an easy-to-use online tool.
This study tests an AI chatbot that provides support to people who have finished breast cancer treatment. It may help you manage survivorship and improve your well-being.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.